Enzolytics Inc (ENZC)

[UncleBilly]

The WSJ Article was good but missing a lot of key info. Looks like the authors had limited space.

The article does not assert Lilly or Regeneron are using monoclonal antibodies derived from humans. It says they develop mabs that "mimic" the human system (or "take a page" etc.).

Go to Lilly and Regeneron website; it tells you how they make their mabs (spoiler alert: not from humans and they don't prevent virus escape as the virus inevitably mutates the same way ENZC does).

ENZC'S methodology has been outlined in great detail by CEO Cotropia. I'm on the run but can be found easily by anyone who wants to find it.

He even explained why Lilly mabs would fail 2 months ago in a PR and why ENZC methodology based on 30+ years of proven science was better. He was right about Lilly as we all know from recent headlines. Given the huge market (many billions), one can conclude that ENZC is in high demand right now. Looking forward to hearing updates from the company. But anyone who thinks this is only a $200M market cap company is kidding themselves. Should be trading 10x this PPS easily. Enjoy the cheapies if they last.